Radiology expertise on your team
Working with RadMD is like having a radiologist on your team. The very foundation of our beliefs hold that radiology expertise is critical to capturing high quality imaging data for internal decision making and regulatory submission.
Flexible & customized for all phases
Phase 1 does not fit a Phase 3 templated design. RadMD adapts processes your unique compound and the imaging needs to meet your goals. Is it a phase 1 go/no-go decision or a non-stop oncology program for FDA submission? A thoughtful approach for all.
Innovative technology
RadMD utilizes best in class technology depending on your trial needs and imaging modality. Options for image workflow, reads and analysis let RadMD tailor tech to budgets and needs of the trial while maintaining the highest quality and compliance standards.
Reader group
Readers are the most important part of the independent image review. Period. Our primary focus has been on building, training, and managing the premier industry reader group.
Global scope
RadMD has worked with sites in over 80 countries. With offices in Philadelphia, Miami and London, we support teams and sites 24/7/365. We have trained over 1000 sites with BRITI site technical training.
Regulatory support
RadMD supports IND, NDA and PMA submissions for over 50 worldwide regulatory agencies.
How can we help?
You need an imaging strategy designed for your trial: one size doesn’t fit all. By choosing RadMD, you can be assured that we will:
- Provide a leading team of specialist clinical trial readers
- Uphold the highest standards of clinical excellence
- Have an unrivalled commitment to innovation, training and education
- Offer a full-service proposition, providing high-value, expert functions
- Develop a genuine and trusted partnership with your team
- Work with you from the development phase through to phase three (or approval)
Diagnostic imaging agents
Unparalleled expertise and a proven track record in bringing drugs to approval
AI validation
RadMD is the global leader providing expert readers, truthers and core lab operations to perform blinded imaging and clinical reviews to meet the rigorous needs in AI imaging trials
We have gained 5 new indications for imaging drugs without performing additional trials.